Last price paid | 0.85 | |
Change | +6.25% [ +0.05 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 15.08.2024 17:20 |
Fixing | n.a. |
Settlement date | 22.09.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +279.55% |
Year to date (YTD) | +183.33% |
1 month | -15.00% |
3 months | -1.16% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.22 |
Underlying price on issue | 652.00 |
Premium | 0.01% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1268391476 |
Symbol | INOQUZ |
Security | 126839147 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Novo Nordisk -B-, DK0062498333 |
Underlying ISIN | DK0062498333 |
Funding level | 603.021500 |
Stop-loss level | 627.142400 |
Distance to stop-loss level | 31.80% |
Long/Short type | Long |
Subscription ratio | 50.00 |
Issuer | Zuercher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 20.09.2023 |
Premium | 1.03% |
Premium p.a. | n.a. |
Leverage | 2.82 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 316.578500 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
UBS | 26.56 |
Sika AG | 259.00 |
NOVARTIS N | 99.68 |
LOGITECH INT. | 78.24 |
Givaudan | 4'201.00 |
Name | Price |
---|---|
GEBERIT N | 517.60 |
Compagnie Financi... | 133.15 |
Alcon AG | 82.22 |
ABB Ltd | 47.29 |
SWISSCOM N | 529.00 |